According to the new research report published by Precedence Research, titled “ US Liquid Biopsy Market (By Biomarker Types: Circulating Tumor Cells (CTCs), Circulating Tumor DNA (CTDNA), Extracellular Vesicles (EVS), Other Biomarkers; By Application: Cancer Therapeutic Application, Reproductive Health, Other Therapeutic Application; By Sample: Blood Sample, Urine Sample, other; By End User: Hospitals and Laboratories, Academic and Research Centers, other End Users) – Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2032 (By Product: Traditional, Advanced; By Application: Pottery, Tiles, Abrasives, Sanitary wave, Bricks & pipes, Others; By End User: Medical, Industrial, Building & Construction, Others) – Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032”, the US liquid biopsy market size is expected to be worth around US$ 1,816.95 million by 2032 and is poised to record a yearly growth rate of 17.48% from 2022 to 2032. The study investigates several elements and their consequences on the growth of the all-wheel drive market.
This report focuses on US liquid biopsy market volume and value at the global level, regional level and company level. From a global perspective, this report represents the overall US liquid biopsy market size by analysing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, the Middle East & Africa, Latin America, etc.
The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2032. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Download a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2474
The study also provides important advancements in organic and inorganic growth strategies in the worldwide US liquid biopsy market. A lot of corporations are prioritizing new launches, product approvals, and other business expansion techniques. In addition, the report offers profiles of US liquid biopsy market firms and market strategies. Furthermore, the research focuses on top industry participants, providing information such as company profiles, components and services offered, recent financial data, and key developments.
US Liquid Biopsy Market Report Scope
| Report Coverage | Details |
| Market Size in 2022 | USD 362.82 Million |
| Market Size by 2032 | USD 1,816.95 Million |
| Growth Rate from 2023 to 2032 | CAGR of 17.48% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | By Biomarker Types, By Application, By Sample, By End User |
Also read: Tissue Diagnostics Market Size to Worth US$ 122.74 Billion by 2032
Market Key Players
Company profiles have been included in the report, which include essentials such as product portfolio, key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting market status and predicting the competition level in the US liquid biopsy market.
Some of the prominent players in the US liquid biopsy market include
- ANGLE plc, Biocept Inc.
- Bio-Rad Laboratories Inc.
- Epigenomics AG
- Exact Sciences Corporation
- F. Hoffmann-La Roche AG
- Guardant Health Inc.
- Illumina Inc.
- MDxHealth SA
- Menarini Silicon Biosystems
- QIAGEN N.V.
- Thermo Fisher Scientific Inc.
US Liquid Biopsy Market Segmentations
By Biomarker Types
- Circulating Tumor Cells (CTCs)
- Circulating Tumor DNA (CTDNA)
- Extracellular vesicles (EVS)
- Other Biomarkers
By Application
- Cancer Therapeutic Application
- Reproductive Health
- Other Therapeutic Application
By Sample
- Blood Sample
- Urine Sample
- Other
By End User
- Hospitals and Laboratories
- Academic and Research Centers
- Other End Users
Report Objectives
- To define, segment, and project the global market size for US liquid biopsy market
- To understand the structure of the market by identifying its various sub-segments
- To provide detailed information about the key factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
- To analyse the micro-markets, with respect to individual growth trends, future prospects, and their contributions to the total market
- To project the size of the market and its submarkets, in terms of value, with respect to global. (along with their respective key countries)
- To profile key players and comprehensively analyse their core competencies
- To understand the competitive landscape and identify major growth strategies adopted by players across the globe.
- To analyse the competitive developments such as expansions & investments, new product launches, mergers & acquisitions, joint ventures, and agreements
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on US Liquid Biopsy Market
5.1. COVID-19 Landscape: US Liquid Biopsy Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. US Liquid Biopsy Market, By Biomarker Types
8.1. US Liquid Biopsy Market, by Biomarker Types, 2023-2032
8.1.1. Circulating Tumor Cells (CTCs)
8.1.1.1. Market Revenue and Forecast (2023-2032)
8.1.2. Circulating Tumor DNA (CTDNA)
8.1.2.1. Market Revenue and Forecast (2023-2032)
8.1.3. Extracellular vesicles (EVS)
8.1.3.1. Market Revenue and Forecast (2023-2032)
8.1.4. Other Biomarkers
8.1.4.1. Market Revenue and Forecast (2023-2032)
Chapter 9. US Liquid Biopsy Market, By Application
9.1. US Liquid Biopsy Market, by Application, 2023-2032
9.1.1. Cancer Therapeutic Application
9.1.1.1. Market Revenue and Forecast (2023-2032)
9.1.2. Reproductive Health
9.1.2.1. Market Revenue and Forecast (2023-2032)
9.1.3. Other Therapeutic Application
9.1.3.1. Market Revenue and Forecast (2023-2032)
Chapter 10. US Liquid Biopsy Market, By Sample
10.1. US Liquid Biopsy Market, by Sample, 2023-2032
10.1.1. Blood Sample
10.1.1.1. Market Revenue and Forecast (2023-2032)
10.1.2. Urine Sample
10.1.2.1. Market Revenue and Forecast (2023-2032)
10.1.3. Other
10.1.3.1. Market Revenue and Forecast (2023-2032)
Chapter 11. US Liquid Biopsy Market, By End User
11.1. US Liquid Biopsy Market, by End User, 2023-2032
11.1.1. Hospitals and Laboratories
11.1.1.1. Market Revenue and Forecast (2023-2032)
11.1.2. Academic and Research Centers
11.1.2.1. Market Revenue and Forecast (2023-2032)
11.1.3. Other End Users
11.1.3.1. Market Revenue and Forecast (2023-2032)
Chapter 12. US Liquid Biopsy Market, Regional Estimates and Trend Forecast
12.1. U.S.
12.1.1. Market Revenue and Forecast, by Biomarker Types (2023-2032)
12.1.2. Market Revenue and Forecast, by Application (2023-2032)
12.1.3. Market Revenue and Forecast, by Sample (2023-2032)
12.1.4. Market Revenue and Forecast, by End User (2023-2032)
Chapter 13. Company Profiles
13.1. ANGLE plc, Biocept Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Bio-Rad Laboratories Inc.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Epigenomics AG
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Exact Sciences Corporation
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. F. Hoffmann-La Roche AG
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Guardant Health Inc.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Illumina Inc.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. MDxHealth SA
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Menarini Silicon Biosystems
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. QIAGEN N.V.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Why should you invest in this report?
If you are aiming to enter the global US liquid biopsy market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for US liquid biopsy are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030 so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
